Since STS is known to trigger Ca2+-dependent apoptosis [42,43], our next step was to compare the protective activity of Bcl-2-BH4 and Bcl-2-BH4 IV/GG in STS-treated C6 glioma cells. This evidence concerns the gene BCL2 and central nervous system cancer.